Search results
Results from the WOW.Com Content Network
The Schedule J of the Drugs and Cosmetics Rules, 1945 of India contains "a list of diseases and ailments which a drug may not claim to prevent or cure".Under Rule 106 of the Drugs and Cosmetics Act, 1940, a drug cannot make claims to treat or prevent any of the diseases or reform the conditions listed.
"Drugs and Cosmetics Rules, 1945" (PDF). Central Drugs Standard Control Organization.Archived from the original (PDF) on 31 October 2005.; A Review on the Current Classification and Regulatory Provisions for Medicines in Drug & Cosmetic Act, in the light of Present Day Context Recommendations for Drugs & Cosmetics Rules with context of Drug Schedules
Schedule H is a class of prescription drugs in India appearing as an appendix to the Drugs and Cosmetics Rules, 1945 introduced in 1945. These are drugs which cannot be purchased over the counter without the prescription of a qualified doctor. The manufacture and sales of all drugs are covered under the Drugs and Cosmetics Act and Rules.
The Drugs and Cosmetics Act, 1940 is an act of the Parliament of India which regulates the import, manufacture and distribution of drugs in India. [1] The primary objective of the act is to ensure that the drugs and cosmetics sold in India are safe, effective and conform to state quality standards. [ 2 ]
The set of standards are published under the title Indian Pharmacopoeia (IP) which has been modeled on and historically follows from the British Pharmacopoeia. The standards that are in effect since 1 December 2010, [ 4 ] are the Indian Pharmacopoeia 2010 (IP 2010) .
A 2021 study reviewed 90 hair transplant clinics and found that the average all-in cost of a hair transplant in the U.S. is roughly $13,610. But how much you pay for hair transplant surgery ...
The following list mentions the names of all substances banned or controlled in India under the NDPS Act. The list uses the International Nonproprietary Name (INN) of the drugs but in some cases mentions drugs by their chemical name. Widely known drugs such as ganja, cocaine, heroin etc. are mentioned by those names.
Dr. VG Somani succeeded S Eswara Reddy, the interim DCGI who was appointed in February 2018. DCGI heads the Indian drug regulatory body the Central Drugs Standard Control Organisation (CDSCO), whose functions include ensuring the quality of drugs and cosmetics sold in the country, approval of new drugs and regulating clinical trials. [3] [4]